برای نمایش بهتر وب سایت از ورژن جدید مرورگر فایرفاکس یا گوگل کروم استفاده نمایید.

دانلود ورژن جدید فایرفاکس دانلود ورژن جدید کروم
English فارسی
logo

مرکز تحقیقات ریزفناوری داروییResearch Center for Pharmaceutical Nanotechnology

فهرست اصلی

System biopharmacy and nanobioinformatics

 

Will be updated ASAP.
 

Technical approach

Will be updated ASAP.


 

Research leaders

Prof. Yadollah Omidi, (PharmD, Ph.D)
Dr. Reza Ferdosi, (M.Sc, Ph.D)
Dr. Mohammad-mostafa Pourseif, (M.Sc, Ph.D)

 

Research Assistants

Will be updated ASAP.

 

Post-doc researchers

Dr. Parvizpour (M.Sc, PhD)

 

Students

PhD Students
 


 
 

 
 
   

 

Selected Publication based on scopus

Last two years publications (2017-2018)
 
1.         Abdollahi-Aghdam A, Majidi MR, Omidi Y. Microfluidic paper-based analytical devices (µPADs) for fast and ultrasensitive sensing of biomarkers and monitoring of diseases. BioImpacts. 2018;8(4):237-40.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056101467&doi=10.15171%2fbi.2018.26&partnerID=40&md5=c674c653dbde0f25069a0698908ef29a

2.         Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y. Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells. BioImpacts. 2018;8(2):117-27.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048082430&doi=10.15171%2fbi.2018.14&partnerID=40&md5=5f8a4a5ed2e47f4ada46ef978cfdd4a9

3.         Akbari Nakhjavani S, Khalilzadeh B, Samadi Pakchin P, Saber R, Ghahremani MH, Omidi Y. A highly sensitive and reliable detection of CA15-3 in patient plasma with electrochemical biosensor labeled with magnetic beads. Biosensors and Bioelectronics. 2018;122:8-15.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053379901&doi=10.1016%2fj.bios.2018.08.047&partnerID=40&md5=c925ecd2ebd8ae18c0a362c531e6c248

4.         Arteshi Y, Aghanejad A, Davaran S, Omidi Y. Biocompatible and electroconductive polyaniline-based biomaterials for electrical stimulation. European Polymer Journal. 2018;108:150-70.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052655195&doi=10.1016%2fj.eurpolymj.2018.08.036&partnerID=40&md5=2ee775b9cc2c2beb4aacd3f11134e449

5.         Asghari S, Movafeghi A, Lisar SYS, Barar J, Omidi Y. Effects of phenanthrene on growth parameters and antioxidant systems in the green microalga chlorella vulgaris. Biointerface Research in Applied Chemistry. 2018;8(4):3405-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052365437&partnerID=40&md5=fdc89489e2d84bf2c4f97641305ed271

6.         Asgharzadeh MR, Barar J, Pourseif MM, Eskandani M, Niya MJ, Mashayekhi MR, et al. Molecular machineries of pH dysregulation in tumor microenvironment: Potential targets for cancer therapy. BioImpacts. 2017;7(2):115-33.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027460324&doi=10.15171%2fbi.2017.15&partnerID=40&md5=0829735dfa89423eb093a6fc07cea2ec

7.         Asoudeh-Fard A, Barzegari A, Dehnad A, Bastani S, Golchin A, Omidi Y. Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signaling pathways. BioImpacts. 2017;7(3):193-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032022290&doi=10.15171%2fbi.2017.22&partnerID=40&md5=ac2f9710e0d21efbaf6eadd4a80bb0ae

8.         Bakhtiary Z, Barar J, Aghanejad A, Saei AA, Nemati E, Ezzati Nazhad Dolatabadi J, et al. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Drug Development and Industrial Pharmacy. 2017;43(8):1244-53.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017243891&doi=10.1080%2f03639045.2017.1310223&partnerID=40&md5=a3a4450cf9f6ed9163e9604b2ef7c165

9.         Borran AA, Aghanejad A, Farajollahi A, Barar J, Omidi Y. Gold nanoparticles for radiosensitizing and imaging of cancer cells. Radiation Physics and Chemistry. 2018;152:137-44.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052432811&doi=10.1016%2fj.radphyschem.2018.08.010&partnerID=40&md5=3541b56118a7bcedc235d59528aac342

10.       Daryanoosh M, Goudarzi G, Rashidi R, Keishams F, Hopke PK, Mohammadi MJ, et al. Risk of morbidity attributed to ambient PM<inf>10</inf>in the western cities of Iran. Toxin Reviews. 2017:1-6.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029411025&doi=10.1080%2f15569543.2017.1370602&partnerID=40&md5=af4f94f3f2ce72fc53ab7f47143e422a

11.       Dehghani J, Adibkia K, Movafeghi A, Barzegari A, Pourseif MM, Maleki Kakelar H, et al. Stable transformation of Spirulina (Arthrospira) platensis: a promising microalga for production of edible vaccines. Applied Microbiology and Biotechnology. 2018;102(21):9267-78.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052698199&doi=10.1007%2fs00253-018-9296-7&partnerID=40&md5=a973db2f6e09da62affb59742cc327ab

12.       Eskandani M, Vandghanooni S, Barar J, Nazemiyeh H, Omidi Y. Cell physiology regulation by hypoxia inducible factor-1: Targeting oxygen-related nanomachineries of hypoxic cells. International Journal of Biological Macromolecules. 2017;99:46-62.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013761924&doi=10.1016%2fj.ijbiomac.2016.10.113&partnerID=40&md5=4d609bc880884abb22a518041b6a9202

13.       Fahimi F, Sarhaddi S, Fouladi M, Samadi N, Sadeghi J, Golchin A, et al. Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori. Applied Microbiology and Biotechnology. 2018;102(16):6899-913.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047945292&doi=10.1007%2fs00253-018-9068-4&partnerID=40&md5=9865ce9575ce57fa5aa503cc230c58cc

14.       Fahimi F, Tohidkia MR, Fouladi M, Aqabeigi R, Samadi N, Omidi Y. Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy. BioImpacts. 2017;7(1):59-71.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019068034&doi=10.15171%2fbi.2017.08&partnerID=40&md5=27df4ff00dca992299baaf7900741991

15.       Fathi M, Majidi S, Zangabad PS, Barar J, Erfan-Niya H, Omidi Y. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer. Medicinal Research Reviews. 2018;38(6):2110-36.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047824876&doi=10.1002%2fmed.21506&partnerID=40&md5=2566096631e3941d12b78325dd476100

16.       Fathi M, Sahandi Zangabad P, Barar J, Aghanejad A, Erfan-Niya H, Omidi Y. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib. International Journal of Biological Macromolecules. 2018;106:266-76.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027684914&doi=10.1016%2fj.ijbiomac.2017.08.020&partnerID=40&md5=e863c26424866b7f5d93d67e01215d6f

17.       Fathi M, Zangabad PS, Aghanejad A, Barar J, Erfan-Niya H, Omidi Y. Folate-conjugated thermosensitive O-maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib. Carbohydrate Polymers. 2017;172:130-41.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019350573&doi=10.1016%2fj.carbpol.2017.05.007&partnerID=40&md5=14fbcf7b855cc5fa0b6748f93b7f9e81

18.       Fathi M, Zangabad PS, Majidi S, Barar J, Erfan-Niya H, Omidi Y. Stimuli-responsive chitosan-based nanocarriers for cancer therapy. BioImpacts. 2017;7(4):269-77.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041008382&doi=10.15171%2fbi.2017.32&partnerID=40&md5=a3481207a7941102508acbaa32214868

19.       Ferdousi R, Safdari R, Omidi Y. Computational prediction of drug-drug interactions based on drugs functional similarities. Journal of Biomedical Informatics. 2017;70:54-64.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019088981&doi=10.1016%2fj.jbi.2017.04.021&partnerID=40&md5=098782278979906f40d9f9cf2d2f249a
20.       Gharaati-Far N, Tohidkia MR, Dehnad A, Omidi Y. Efficiency and cytotoxicity analysis of cationic lipids-mediated gene transfection into AGS gastric cancer cells. Artificial Cells, Nanomedicine and Biotechnology. 2018;46(5):1001-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025432439&doi=10.1080%2f21691401.2017.1355311&partnerID=40&md5=a3cdfc55a52ef3259f8757b28e68e386

21.       Goudarzi G, Daryanoosh SM, Godini H, Hopke PK, Sicard P, De Marco A, et al. Health risk assessment of exposure to the Middle-Eastern Dust storms in the Iranian megacity of Kermanshah. Public Health. 2017;148:109-16.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018443434&doi=10.1016%2fj.puhe.2017.03.009&partnerID=40&md5=118cb4edffb7174767f7edb4c8ed3a79

22.       Jafarizad A, Aghanejad A, Sevim M, Metin Ö, Barar J, Omidi Y, et al. Gold Nanoparticles and Reduced Graphene Oxide-Gold Nanoparticle Composite Materials as Covalent Drug Delivery Systems for Breast Cancer Treatment. ChemistrySelect. 2017;2(23):6663-72.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041836352&doi=10.1002%2fslct.201701178&partnerID=40&md5=6b0fbea4224f638561de41f6c3d258db

23.       Karami P, Majidi MR, Johari-Ahar M, Barar J, Omidi Y. Development of screen-printed tryptophan-kynurenine immunosensor for in vitro assay of kynurenine-mediated immunosuppression effect of cancer cells on activated T-cells. Biosensors and Bioelectronics. 2017;92:287-93.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006493516&doi=10.1016%2fj.bios.2016.11.010&partnerID=40&md5=edf3bfa31406b3199bdbafafe9ee161f

24.       Khajeh S, Tohidkia MR, Aghanejad A, Mehdipour T, Fathi F, Omidi Y. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells. Artificial Cells, Nanomedicine and Biotechnology. 2018:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048189454&doi=10.1080%2f21691401.2018.1478846&partnerID=40&md5=c380e2f8405070fb03565a8153786c0c

25.       Maleki Kakelar H, Barzegari A, Dehghani J, Hanifian S, Saeedi N, Barar J, et al. Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination. Gastric Cancer. 2018.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052663819&doi=10.1007%2fs10120-018-0867-1&partnerID=40&md5=001fe9f33fed1270945f9b525363283a

26.       Mesgari-Shadi A, Sarrafzadeh MH, Barar J, Omidi Y. Cost-effective batch production process of scFv antibody in Escherichia coli. Human Antibodies. 2017;26(3):149-57.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047346843&doi=10.3233%2fHAB-180333&partnerID=40&md5=915f30b6a94c90f2b0f4346a9193cd20

27.       Mesgari-Shadi A, Sarrafzadeh MH, Divband B, Barar J, Omidi Y. Batch adsorption/desorption for purification of scFv antibodies using nanozeolite microspheres. Microporous and Mesoporous Materials. 2018;264:167-75.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041469002&doi=10.1016%2fj.micromeso.2018.01.028&partnerID=40&md5=28865cc8862f3d164597a2826580f3f9

28.       Mohammadi MJ, Yari AR, Saghazadeh M, Sobhanardakani S, Geravandi S, Afkar A, et al. A health risk assessment of heavy metals in people consuming Sohan in Qom, Iran. Toxin Reviews. 2017:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028539918&doi=10.1080%2f15569543.2017.1362655&partnerID=40&md5=b6fbf045c1c7b21deb47e9a81c6d4566

29.       Momtazan M, Geravandi S, Rastegarimehr B, Valipour A, Ranjbarzadeh A, Yari AR, et al. An investigation of particulate matter and relevant cardiovascular risks in Abadan and Khorramshahr in 2014–2016. Toxin Reviews. 2018:1-8.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045837160&doi=10.1080%2f15569543.2018.1463266&partnerID=40&md5=f22d5ddfffe0b78faf65bd8070f5854e

30.       Nakhlband A, Eskandani M, Omidi Y, Saeedi N, Ghaffari S, Barar J, et al. Combating atherosclerosis with targeted nanomedicines: Recent advances and future prospective. BioImpacts. 2018;8(1):59-75.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044298919&doi=10.15171%2fbi.2018.08&partnerID=40&md5=c44d352eea40fe79a5840b756e3d8c49

31.       Nakhlband A, Eskandani M, Saeedi N, Ghafari S, Omidi Y, Barar J, et al. Marrubiin-loaded solid lipid nanoparticles’ impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect. Colloids and Surfaces B: Biointerfaces. 2018;164:299-307.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041484199&doi=10.1016%2fj.colsurfb.2018.01.046&partnerID=40&md5=75a93e53a55737af8ff5751d49c96e8d

32.       Neisi A, Albooghobeish M, Geravandi S, Adeli Behrooz HR, Mahboubi M, Omidi Khaniabad Y, et al. Investigation of health risk assessment sevoflurane on indoor air quality in the operation room in Ahvaz city, Iran. Toxin Reviews. 2018:1-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042079259&doi=10.1080%2f15569543.2018.1434796&partnerID=40&md5=7743c13a195a1e81870c69af75f654d0

33.       Neisi A, Idani E, Vosoughi M, Hazrati S, Babaei AA, Takdastan A, et al. Answers to the comments on “Air pollution, biological marker and lung function in children”. Environmental Science and Pollution Research. 2018;25(27):27669-71.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85051662886&doi=10.1007%2fs11356-018-2905-2&partnerID=40&md5=67ebae1b334f8ee7ae0b9613c4dbb3c5

34.       Nemati E, Azami A, Mokhtarzadeh A, Rahbar Saadat Y, Omidi Y, Ezzati Nazhad Dolatabadi J. Formulation and characterization of ethambutol loaded nanostructured lipid carrier. Latin American Journal of Pharmacy. 2017;36(2):247-52.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009188311&partnerID=40&md5=0dd9090004b9a8389b901191bc5aa7b0

35.       Omidi Khaniabadi Y, Sicard P, Omidi Khaniabadi A, Mohammadinejad S, Keishams F, Takdastan A, et al. Air quality modeling for health risk assessment of ambient PM<inf>10</inf>, PM<inf>2.5</inf> and SO<inf>2</inf> in Iran. Human and Ecological Risk Assessment. 2018.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056076901&doi=10.1080%2f10807039.2018.1487277&partnerID=40&md5=4ad5db9621bada963912faeefebe885c

36.       Pakchin PS, Nakhjavani SA, Saber R, Ghanbari H, Omidi Y. Recent advances in simultaneous electrochemical multi-analyte sensing platforms. TrAC - Trends in Analytical Chemistry. 2017;92:32-41.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019062608&doi=10.1016%2fj.trac.2017.04.010&partnerID=40&md5=86f1d82fb0a639bf442abe990251d8d4

37.       Panahpour H, Farhoudi M, Omidi Y, Mahmoudi J. An in vivo assessment of blood-brain barrier disruption in a rat model of ischemic stroke. Journal of Visualized Experiments. 2018;2018(133).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044652743&doi=10.3791%2f57156&partnerID=40&md5=3d54e84e447224149ceec28d52000563

38.       Parvizpour S, Razmara J, Omidi Y. Breast cancer vaccination comes to age: Impacts of bioinformatics. BioImpacts. 2018;8(3):223-35.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050689925&doi=10.15171%2fbi.2018.25&partnerID=40&md5=35bbff349a89fb1923d5cd2987fea1b2

39.       Pourseif MM, Moghaddam G, Daghighkia H, Nematollahi A, Omidi Y. A novel B- and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus. BioImpacts. 2018;8(1):39-52.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044310762&doi=10.15171%2fbi.2018.06&partnerID=40&md5=ea0ff8f030d068035ab94721a89bd101

40.       Pourseif MM, Moghaddam G, Naghili B, Saeedi N, Parvizpour S, Nematollahi A, et al. A novel in silico minigene vaccine based on CD4+ T-helper and B-cell epitopes of EG95 isolates for vaccination against cystic echinococcosis. Computational Biology and Chemistry. 2018;72:150-63.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85035245058&doi=10.1016%2fj.compbiolchem.2017.11.008&partnerID=40&md5=b0f720db7f8ae2e7b24b3291b687b69c

41.       Pourseif MM, Moghaddam G, Saeedi N, Barzegari A, Dehghani J, Omidi Y. Current status and future prospective of vaccine development against Echinococcus granulosus. Biologicals : journal of the International Association of Biological Standardization. 2018;51:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032934489&doi=10.1016%2fj.biologicals.2017.10.003&partnerID=40&md5=6e58b3fd4e237e6da7d3f19237f99091

42.       Rahmanian N, Eskandani M, Barar J, Omidi Y. Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines. Journal of Drug Targeting. 2017;25(3):202-15.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85013790692&doi=10.1080%2f1061186X.2016.1238475&partnerID=40&md5=bd598c4cfefb872b3e2a2475014d55e9

43.       Ranjbar-Navazi Z, Eskandani M, Johari-Ahar M, Nemati A, Akbari H, Davaran S, et al. Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy. Journal of Drug Targeting. 2018;26(3):267-77.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85028533760&doi=10.1080%2f1061186X.2017.1365876&partnerID=40&md5=ecb973a8ad3ac8a67a759bfe5c6554a7

44.       Rodriguez-Ruiz V, Salatti-Dorado JÁ, Barzegari A, Nicolas-Boluda A, Houaoui A, Caballo C, et al. Astaxanthin-loaded nanostructured lipid carriers for preservation of antioxidant activity. Molecules. 2018;23(10).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054802470&doi=10.3390%2fmolecules23102601&partnerID=40&md5=4c189dcfc787a799bb20b92924979f3d

45.       Salmanzadeh R, Eskandani M, Mokhtarzadeh A, Vandghanooni S, Ilghami R, Maleki H, et al. Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics. Food Bioscience. 2018;24:37-45.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047079935&doi=10.1016%2fj.fbio.2018.05.005&partnerID=40&md5=86ec63b293c96c30b9a73dbb9b725882

46.       Samadi Pakchin P, Ghanbari H, Saber R, Omidi Y. Electrochemical immunosensor based on chitosan-gold nanoparticle/carbon nanotube as a platform and lactate oxidase as a label for detection of CA125 oncomarker. Biosensors and Bioelectronics. 2018;122:68-74.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053459986&doi=10.1016%2fj.bios.2018.09.016&partnerID=40&md5=4e7807561adf7ec2508472fd649146b5

47.       Shakoori Z, Ghanbari H, Omidi Y, Pashaiasl M, Akbarzadeh A, Jomeh Farsangi Z, et al. Fluorescent multi-responsive cross-linked P(N-isopropylacrylamide)-based nanocomposites for cisplatin delivery. Drug Development and Industrial Pharmacy. 2017;43(8):1283-91.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017592278&doi=10.1080%2f03639045.2017.1313859&partnerID=40&md5=956a7b3a3d2c98a956bb934cd76db1fd

48.       Tohidkia MR, Sepehri M, Khajeh S, Barar J, Omidi Y. Improved Soluble ScFv ELISA Screening Approach for Antibody Discovery Using Phage Display Technology. SLAS Discovery. 2017;22(8):1026-34.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019103807&doi=10.1177%2f2472555217701059&partnerID=40&md5=af31b18c9d2b27f21c12bcabf6ab2098

49.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells. Nanomedicine. 2018;13(21).  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056644400&doi=10.2217%2fnnm-2018-0205&partnerID=40&md5=161fbb8b5bb78dce38d0ba61eedafcd7

50.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective. Journal of Molecular Medicine. 2018;96(9):885-902.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050732999&doi=10.1007%2fs00109-018-1669-y&partnerID=40&md5=74c22af238864e7d1d869770b489bc80

51.       Vandghanooni S, Eskandani M, Barar J, Omidi Y. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer. European Journal of Pharmaceutical Sciences. 2018;117:301-12.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043258625&doi=10.1016%2fj.ejps.2018.02.027&partnerID=40&md5=dd05d32378ddc2b49636836862d6604b

52.       Zamanlu M, Farhoudi M, Eskandani M, Mahmoudi J, Barar J, Rafi M, et al. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke. Journal of Drug Targeting. 2018;26(2):95-109.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041324095&doi=10.1080%2f1061186X.2017.1365874&partnerID=40&md5=89cb1d43d0465373462ee13f3fda5150

53.       Zeydouni G, Kianizadeh M, Omidi Khaniabadi Y, Nourmoradi H, Esmaeili S, Mohammadi MJ, et al. Eriochrme black-T removal from aqueous environment by surfactant modified clay: equilibrium, kinetic, isotherm, and thermodynamic studies. Toxin Reviews. 2018:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045213969&doi=10.1080%2f15569543.2018.1455214&partnerID=40&md5=2095548ed9344e26d9a044e28ea026b1

54.       Zeydouni G, Rodriguez Couto S, Nourmoradi H, Basiri H, Amoatey P, Esmaeili S, et al. H<inf>2</inf>SO<inf>4</inf>-modified Aloe vera leaf shells for the removal of P-chlorophenol and methylene blue from aqueous environment. Toxin Reviews. 2018:1-11.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049807048&doi=10.1080%2f15569543.2018.1478857&partnerID=40&md5=bdf7de5b7ece62088ae83ed875b9ce03

55.       Zununi Vahed S, Barzegari A, Rahbar Saadat Y, Goreyshi A, Omidi Y. Leuconostoc mesenteroides-derived anticancer pharmaceuticals hinder inflammation and cell survival in colon cancer cells by modulating NF-κB/AKT/PTEN/MAPK pathways. Biomedicine and Pharmacotherapy. 2017;94:1094-100.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027844768&doi=10.1016%2fj.biopha.2017.08.033&partnerID=40&md5=d08e9c996121bc668e1cd915103e9429

56.       Zununi Vahed S, Moghaddas Sani H, Rahbar Saadat Y, Barzegari A, Omidi Y. Type 1 diabetes: Through the lens of human genome and metagenome interplay. Biomedicine and Pharmacotherapy. 2018;104:332-42.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047069658&doi=10.1016%2fj.biopha.2018.05.052&partnerID=40&md5=e7ec61ac2dd58c29426051bbb3577643

57.       Zununi Vahed S, Omidi Y, Ardalan M, Samadi N. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Clinical Biochemistry. 2017;50(1-2):32-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-84981743382&doi=10.1016%2fj.clinbiochem.2016.08.007&partnerID=40&md5=dce5e69110b5bc9c9653cc93e28cc807

58.       Zununi Vahed S, Poursadegh Zonouzi A, Ghanbarian H, Ghojazadeh M, Samadi N, Omidi Y, et al. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function. International Urology and Nephrology. 2017;49(9):1681-9.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018254073&doi=10.1007%2fs11255-017-1602-2&partnerID=40&md5=0d7967abbcfdfe2675a89d83f9394a92

59.       Zununi Vahed S, Poursadegh Zonouzi A, Mahmoodpoor F, Samadi N, Ardalan M, Omidi Y. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction. Archives of Medical Research. 2017;48(1):96-104.  https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020124194&doi=10.1016%2fj.arcmed.2017.03.004&partnerID=40&md5=bc4c9715013ee59126af3fcfd94c159b